LentiGlobin BB305 gene therapy: Additional Phase I/II data

Data from the first 2 patients with beta thalassemia major who received autologous hematopoietic stem cell transplantation (HSCT) with LentiGlobin BB305 in the open-label, international Phase I/II Nor...